Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Open in API
Filings indexed 1,611 across all filing types
Latest filing 2019-08-14 Regulatory Filings
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
108年第2季海外子公司投資
Regulatory Filings Classification · 90% confidence The document is a financial disclosure related to investment holdings in overseas subsidiaries, showing investment amounts, shareholding percentages, and recognized investment gains or losses for a specific quarter (108年2季, which corresponds to Q2 of the 108th year in the Taiwanese calendar, roughly 2019). The document length is short (1078 characters) and it contains tabular financial data about investments but does not include comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR). It appears to be a regulatory disclosure of investment holdings and results rather than a full financial report. Given the short length and nature of the data, it is most consistent with a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2019-08-14 Chinese
108年第2季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts, investment methods, and related financial figures concerning the company's investments in mainland China. It includes specific financial data such as capital amounts, investment income, and investment losses for the reporting period (Year 108, Quarter 2). The document is relatively short (1498 characters) and focuses on investment details rather than a full financial report or earnings release. It does not appear to be an announcement of a report publication or a certification. The content aligns with regulatory disclosure requirements about overseas investments, which typically fall under Regulatory Filings (RNS) as they do not constitute a full annual or interim report, nor a specific category like earnings release or capital update. Therefore, the best classification is Regulatory Filings (RNS).
2019-08-14 Chinese
108年第2季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the second quarter of the fiscal year 108 (which corresponds to 2019 in the Gregorian calendar). It includes detailed financial data such as cash flows from operating, investing, and financing activities, with specific amounts and accounting items. The presence of actual financial statements for a period shorter than a full fiscal year (half-year or quarterly) indicates this is an Interim / Quarterly Report. The document length is 2498 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2019
2019-08-13 Chinese
108年第2季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement with detailed financial data for the second quarter and half-year periods of the fiscal year 108 (Taiwan calendar, corresponding to 2019). It includes revenue, costs, expenses, profit/loss, and earnings per share figures. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is a quarterly or interim financial report. The document length is 3565 characters, which is sufficient to contain actual financial data rather than just an announcement. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2019
2019-08-13 Chinese
108年第2季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific dates such as June 30, 2019 (108年第2季) and December 31, 2018. The content is financial in nature, showing assets, liabilities, and equity, which is typical of a financial report. The document length is 3997 characters, which is under 5000 characters, but it contains substantive financial data rather than just an announcement or a link to a report. The presence of detailed financial statements for a quarter suggests this is an Interim / Quarterly Report rather than a full Annual Report or just an announcement. There is no indication that this is a certification, announcement, or other type of filing. Therefore, the best classification is Interim / Quarterly Report (IR). Q2 2019
2019-08-13 Chinese
108年第2季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial tables showing changes in equity for a company over two half-year periods (民國108年上半年度 and 民國107年上半年度), including items such as common stock, capital surplus, legal reserves, retained earnings, and other equity components. The presence of comprehensive financial data for a half-year period indicates this is a financial report for an interim period rather than a brief announcement or a certification. The document length is 4443 characters, which is relatively short but contains substantive financial data, not just a notice or link to a report. The content matches the characteristics of an Interim / Quarterly Report (IR) as it provides detailed financial statements and analysis for a period shorter than a full fiscal year (half-year). H1 2019
2019-08-13 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.